Triglyceride reduction in secondary atherosclerotic cardiovascular disease prevention: core concepts in contemporary therapeutic targeting,European Heart Journal

当前位置： X-MOL 学术 › Eur. Heart J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Triglyceride reduction in secondary atherosclerotic cardiovascular disease prevention: core concepts in contemporary therapeutic targeting
European Heart Journal ( IF 39.3 ) Pub Date : 2020-03-10 , DOI: 10.1093/eurheartj/ehaa078
Patrick R Lawler _{1,

2,

3} , Robert S Rosenson ₄ , Dennis T Ko _{3,

5}

Affiliation

This commentary refers to ‘Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies’, by P.R. Lawler et al., 2020;41:86–94.

中文翻译：